aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Market

76.04USD
3 Feb 2014
Change (% chg)

$-0.03 (-0.04%)
Prev Close
$76.07
Open
$76.09
Day's High
$76.09
Day's Low
$76.02
Volume
1,059,042
Avg. Vol
--
52-wk High
--
52-wk Low
--

LIFE.OQ

Chart for LIFE.OQ

About

aTyr Pharma, Inc. (aTyr) is a United States-based bio-therapeutics company. The Company is engaged in the discovery and clinical development of Physiocrine-based therapeutics, which act as endogenous modulators of the immune system. The Company's programs are focused on rare immunomodulation disorders in the areas of inflammatio... (more)
No analyst recommendations are available for LIFE.OQ.

Overall

No Ratios Available.

Financials

  LIFE.OQ Industry Sector
P/E (TTM): -- 155.83 41.17
EPS (TTM): -- -- --
ROI: -- -1.02 16.08
ROE: -- -2.93 16.92
Search Stocks

Thermo Fisher Q4 results top expectations on Life Tech buy

Jan 29 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported better-than-expected quarterly profit and sales, boosted by the contribution from the Life Technologies acquisition.

29 Jan 2015

Thermo Fisher profit jumps but revenue disappoints, shares drop

- Thermo Fisher Scientific Inc , said quarterly profit rose nearly 49 percent, boosted by the acquisition of genetic testing company Life Technologies, but shares fell 3 percent as revenue growth disappointed investors.

22 Oct 2014

UPDATE 1-Thermo Fisher profit jumps but revenue disappoints, shares drop

(New throughout, updates share price, adds details and analyst comments)

22 Oct 2014

Thermo Fisher profit jumps as Life Tech buyout pays off

Oct 22 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported an about 49 percent rise in quarterly profit as it benefited from the acquisition of genetic testing company Life Technologies.

22 Oct 2014

Earnings vs. Estimates

No consensus analysis data available.
Search Stocks